SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-045437
Filing Date
2023-12-19
Accepted
2023-12-19 17:00:51
Documents
31
Period of Report
2023-12-13
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50178
2 ex99-1.htm EX-99.1 17247
3 ex99-1_001.jpg GRAPHIC 425378
4 ex99-1_002.jpg GRAPHIC 617854
5 ex99-1_003.jpg GRAPHIC 265779
6 ex99-1_004.jpg GRAPHIC 354914
7 ex99-1_005.jpg GRAPHIC 384709
8 ex99-1_006.jpg GRAPHIC 395183
9 ex99-1_007.jpg GRAPHIC 234911
10 ex99-1_008.jpg GRAPHIC 247324
11 ex99-1_009.jpg GRAPHIC 370385
12 ex99-1_010.jpg GRAPHIC 301680
13 ex99-1_011.jpg GRAPHIC 282356
14 ex99-1_012.jpg GRAPHIC 271911
15 ex99-1_013.jpg GRAPHIC 252160
16 ex99-1_014.jpg GRAPHIC 272004
17 ex99-1_015.jpg GRAPHIC 236221
18 ex99-1_016.jpg GRAPHIC 381804
19 ex99-1_017.jpg GRAPHIC 428829
  Complete submission text file 0001493152-23-045437.txt   8174349

Data Files

Seq Description Document Type Size
20 XBRL SCHEMA FILE cldi-20231213.xsd EX-101.SCH 3893
21 XBRL DEFINITION FILE cldi-20231213_def.xml EX-101.DEF 26803
22 XBRL LABEL FILE cldi-20231213_lab.xml EX-101.LAB 37082
23 XBRL PRESENTATION FILE cldi-20231213_pre.xml EX-101.PRE 25427
25 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5707
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40789 | Film No.: 231498248
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)